BIOTECH & LIFE SCIENCES
innovations Remarkable Siân John, CTO of NCC
Group outlines some of the key cyber security threats and solutions faced by the biotech industry
T
he biotech industry is on the cusp of many remarkable innovations, driven by advanced robotics,
sophisticated data analytics, and cutting-edge artifi cial intelligence (AI). From fully robotic genome foundries, like the one I recently visited through EPSRC at the University of Edinburgh, to the myriads of interconnected devices collecting and processing samples, the sector is rapidly evolving. However, as we embrace these
technological advancements, it is essential that labs implement robust cybersecurity measures. Protecting sensitive data, ranging from intellectual property (IP) to personal health information (PHI), is critical to maintaining the integrity and trust in the biotech industry.
ROBOTICS AND AI IN BIOTECH Biotechnology today relies heavily on advanced robotics and computing power. These technologies facilitate the high-throughput collection and processing of biological samples and enable intensive data analysis, which is crucial for running complex models and deriving detailed results. For instance, the Edinburgh Genome Foundry exemplifi es how robotic
systems can revolutionise genomics by automating the synthesis and assembly of DNA sequences. Such advancements not only accelerate research but also reduce human error, enhancing the reliability of experimental outcomes. However, this heavy reliance on
technology also introduces signifi cant cyber-security challenges. The data processed in these labs is highly sensitive. It includes proprietary research data that represents signifi cant IP, as well as personal data from individuals who provide biological samples. The potential for data breaches in this context is high, and the consequences can be severe, ranging from the theft of valuable IP to the exposure of personal health information.
THE VALUE OF DATA In the biotech industry, data is gold. Research data underpins the development of new therapies, drugs, and biotechnologies. This data, often generated through years of meticulous research, holds immense IP value. Cyberattacks targeting this data can lead to signifi cant fi nancial losses, damage to reputation, and setbacks in scientifi c progress. Equally important is the privacy of
individuals who contribute biological samples for research. These samples
can reveal a wealth of PHI. In the wrong hands, such data can be misused for identity theft, insurance fraud, or other malicious activities. The biotech industry must, therefore, ensure that data protection is a top priority, safeguarding both the interests of researchers and the privacy of individuals.
ADAPTING TO CYBER THREATS IN BIOTECH The cyber security landscape is continuously evolving, as are the threats – these can take the form of: • Targeted attacks: Hackers may specifi cally target biotech companies to steal valuable IP or disrupt operations.
• Insider threats: Employees with access to sensitive data might intentionally or unintentionally compromise security.
• Supply-chain vulnerabilities: The integration of multiple technologies and third-party services can introduce weaknesses that attackers can exploit.
• Advanced persistent threats (APTs): Prolonged and targeted cyberattacks that aim to infi ltrate and remain within systems to steal data over an extended period, without detection.
www.scientistlive.com 39
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
